戻る Agenda
LS12: How should We Collaborate Together to Enhance Model-Informed Drug Development?
Session Chair(s)
Atsushi Tsukamoto, PHD, MSC
Head is Therapeutic Area Strategies , Daiichi Sankyo, United States
Speaker(s)
Takayo Ueno
Director, Clinical Pharmacology Strategy, Bristol Myers Squibb, Japan
Norisuke Kawai, PHD
Senior Director, Head of Clinical Research, Pfizer R&D Japan G.K., Japan
Daisuke Iwata
Office of Asia Training Center and International cooperation, Pharmaceuticals and Medical Devices Agency, Japan